Na-enyocha...
Atụgharịrị ya na-akpaghị aka. Maka ọnụọgụ ọgwụ na ịdọ aka ná ntị: lee nke mbụ n'asụsụ Bekee. Gụọ n'asụsụ Bekee
Home / Registered in Nigeria / SkinoRita Cream

SkinoRita Cream

NAFDAC Reg. No. A4-100358 · Drug

Registered with NAFDAC. Registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
SkinoRita Cream
NAFDAC number
A4-100358
Active ingredient
Urea; Latic acid; Glycine; Ammonium chloride; Sodium Chloride; Potassium chloride; Calcium lactate; Magnesium chloride; Sodium dihydrogen phosphate dihydrate; Stearic acid; Cetyl Alcohol; Glycerin; Disodium Edetate
Strength
see Composition
Form
Cream
Pack size
1 x 100 g (in HDPE jar)
Manufacturer
Not listed
Applicant (holder)
The Devon Pharmaceuticals Company Limited
Approved
28 Mar 2023
Status
Active View on NAFDAC ↗
Registration valid to
27 Mar 2028
WHO alerts
None found
Community reports
None
Times checked
0

About the medicine: Urea: uses, dosage and brands worldwide

What we found

  • SkinoRita Cream is on the NAFDAC register with an active registration (A4-100358). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use SkinoRita Cream

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

1.5% Glycine Irrigation, USP is indicated for use as irrigating fluid during transurethral prostatic resection and other transurethral surgical procedures.

How to take it and how often
  • 1.5% Glycine Irrigation, USP should be administered only by transurethral instillation with appropriate urologic instrumentation
  • A disposable irrigation set should be used
  • The total volume of solution used for irrigation is solely at the discretion of the surgeon
  • Height of container(s) above the operating table in excess of 60 cm (approx. 2 ft.) has been reported to increase intravascular absorption of the irrigating fluid
  • Drug Interactions Additives may be incompatible
  • Consult with pharmacist, if available
  • When introducing additives, use aseptic technique, mix thoroughly and do not store
  • Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution container permits
  • See PRECAUTIONS
Children
  • The safety and effectiveness of Glycine Irrigation have not been established
  • Its limited use
  • In pediatric patients has been inadequate to fully define proper dosage and limitations for use
Talk to a doctor first if
  • NOT FOR INJECTION BY USUAL PARENTERAL ROUTES
  • Do not use in patients with anuria
Warnings

FOR UROLOGIC IRRIGATION ONLY. Solutions for urologic irrigation must be used with caution in patients with severe cardiopulmonary or renal dysfunction. Irrigating fluids used during transurethral prostatectomy have been demonstrated to enter the systemic circulation in relatively large volumes. Thus, glycine irrigating solution must be regarded as a systemic drug. Absorption of large amounts of fluids containing glycine may significantly alter cardiopulmonary and renal dynamics. Do not heat container over 66°C (150°F).

Possible side effects

Adverse reactions may result from intravascular absorption of glycine. Large intravenous doses of glycine are known to cause salivation, nausea and lightheadedness. Other consequences of absorption of urologic irrigating solutions include fluid and electrolyte disturbances such as acidosis, electrolyte loss, marked diuresis, urinary retention, edema, dryness of mouth, thirst, dehydration, coma from hyponatremia, secondary hyponatremia due to fluid overload, and hyperammonemia with resultant coma and/or encephalopathy; cardiovascular disorders such as hypotension, tachycardia, angina-like pains; pulmonary disorders such as pulmonary congestion; and other general reactions such as blurred visi …

Pregnancy and breastfeeding

Pregnancy: Teratogenic Effects. Pregnancy Category C. Animal reproduction studies have not been conducted with Glycine Irrigation, USP. It is also not known whether Glycine Irrigation, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Glycine Irrigation, USP should be given to a pregnant woman only if clearly needed.

If you take too much

In the event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS, PRECAUTIONS and ADVERSE REACTIONS.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-10-21.

Label for urea and latic acid and glycine and ammonium chloride and sodium chloride and potassium chloride and calcium lactate and magnesium chloride and sodium dihydrogen phosphate dihydrate and stearic acid and cetyl alcohol and glycerin and disodium edetate, the active ingredient registered with NAFDAC.

Check your pack of SkinoRita Cream

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About SkinoRita Cream

What is in SkinoRita Cream?

SkinoRita Cream contains Urea; Latic acid; Glycine; Ammonium chloride; Sodium Chloride; Potassium chloride; Calcium lactate; Magnesium chloride; Sodium dihydrogen phosphate dihydrate; Stearic acid; Cetyl Alcohol; Glycerin; Disodium Edetate (see Composition), as cream, according to its NAFDAC registration record.

Is SkinoRita Cream registered with NAFDAC?

Yes. SkinoRita Cream is listed on the NAFDAC register under registration number A4-100358, and its registration is active as of 5 November 2026.

Has SkinoRita Cream been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches SkinoRita Cream in our automatically synced alert list.

How can I check that my pack of SkinoRita Cream is genuine?

Run a free authenticity scan with the NAFDAC number A4-100358, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take SkinoRita Cream?

Follow your prescription or the leaflet in your pack. The official label says: 1.5% Glycine Irrigation, USP should be administered only by transurethral instillation with appropriate urologic instrumentation. A disposable irrigation set should be used. The total volume of solution used for irrigation is solely at the discretion of the surgeon. Height of container(s) above the operating table in excess of 60 cm (approx. 2 ft.) has been reported to increase…

What is SkinoRita Cream used for?

1.5% Glycine Irrigation, USP is indicated for use as irrigating fluid during transurethral prostatic resection and other transurethral surgical procedures. (Summarised from the official U.S. FDA label for urea and latic acid and glycine and ammonium chloride and sodium chloride and potassium chloride and calcium lactate and magnesium chloride and sodium dihydrogen phosphate dihydrate and stearic acid and cetyl alcohol and glycerin and disodium edetate. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used SkinoRita Cream? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.